Tuesday 6 October

11.00–11.15Welcome to HIV Glasgow Day Two

11.15–12.00Keynote Lecture: Obesity and HIV
Andrew Carr, Melbourne, Australia

12.00–13.00Biological, Clinical and Ethical Imperatives for Involving Diverse Women
in Clinical Trials

In collaboration with the International AIDS Society (IAS)

12.00–12.05Welcome and introduction
Linda-Gail Bekker, Cape Town, South Africa

12.05–12.15Biological considerations for including women in clinical trials

12.15–12.25Importance of including women in trials from a programming point of view

12.25–12.35Ethical considerations: why it’s imperative to include women in clinical trials

12.35–12.50Motivations and experiences as women in clinical trials

12.50–13.00Panel discussion and live Q&A


13.15–14.30Industry Symposium

14.30–15.30Scientific Posters including Thistles

15.30–16.30HIV Care in the COVID-19 Era: A Community Perspective
In collaboration with the European AIDS Treatment Group (EATG)

15:30-15:40Overview of services and impact on prevention and care and psychosocial
implications on PLHIV

Ian Hodgson, Yorkshire, UK

15:40-15:50Rights, emergency measures and beyond
Julian Hows, Amsterdam, The Netherlands

15:50-16:10Community responses to disruption caused by the COVID-19 crisis

16:10-16:30Discussion and closing remarks


17.00–18.00Challenging Cases in HIV
In collaboration with the International Antiviral Society-USA (IAS-USA)